NEW YORK (GenomeWeb News) – Roche has reached an agreement with Innovatis to buy the cell analysis company for €15 million ($19.5 million), the Swiss life sciences firm said today.

Roche said that the acquisition of the Bielefeld, Germany-based company, which focuses on automated cell analysis solutions including cell counting, viability testing, and cell function, fits with its strategy to strengthen its cell research market offerings.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.